| Name | THJ |
|---|
| Formal Name | 1-pentyl-N-(quinolin-8-yl)-1H-indazole-3-carboxamide |
|---|
| SMILES | O=C(Nc2cccc1cccnc12)c4nn(CCCCC)c3ccccc34 |
|---|
| InChI Key | YAYIQXMTUCPLHG-UHFFFAOYAY |
|---|
| InChI Code | InChI=1/C22H22N4O/c1-2-3-6-15-26-19-13-5-4-11-17(19)21(25-26)22(27)24-18-12-7-9-
16-10-8-14-23-20(16)18/h4-5,7-14H,2-3,6,15H2,1H3,(H,24,27) |
|---|
| Description | THJ is a synthetic cannabinoid designer drug that is similar to other indazole-based compound including MN-018, differing only by the replacement of the 1-naphthyl amide moiety with an 8-quinolinyl amide, and 5F-THJ with a fluorine at the pentyl terminus. 5F-THJ was first observed on illicit Internet drug sites in the summer of 2013. Although the physiological and toxicological properties of this compound have not yet been reported, other pentyl substituted indazole-based cannabinoid agonists with reported binding affinities such as AKB48 have been detected in herbal smoking mixtures. |
|---|
Status |
Verified |
|---|
| Submitted | 2014-11-17 |
|---|
| Submitted By | Cayman Chemical
Queensland Health Forensic and Scientific Services Data |
|---|
| Published | 2015-08-05 |
|---|
| Contact | Paul D. Kennedy, PhD. at Cayman Chemical |
|---|
| Product Details | Link |
|---|
Monograph |
Download the THJ Monograph |
|---|
|
|
